• Background
logo
  • Home
  • Who we are
    Who we are
    • Overview
    • Chairman's Profile
    • Board of Directors
    • Team Wockhardt
    • Collaborations / Partnerships
    Faclities
    • Manufacturing
    • Contract Manufacturing
    • Virtual Tour
    Global Presence
    • Our Footprints
    • Other websites
    Community Care
    • Wockhardt Foundation
  • We touch lives
    R & D
    • Overview
    • Generics
    • New Drug Discovery
    Biotechnology
    • Overview
    • Biopharmaceuticals
    • Biotechnology Park
    • Gallery
    Corporate Regulatory
    • Marketing & Regulatory Infrastructure
  • Products
    • Search Products
  • People
    • Frequently Asked Questions
    • Life at Wockhardt
    • Focus on Development
    • Wockhardt Anthem
    • Meet our People
    • Wockhardt on LinkedIn
    • Career Openings
  • Investors
    • Financials at a glance
    • Annual Reports
    • AGM Notice
    • Chairman's AGM Speeches
    • Other Shareholders Services
    • Quarterly Results
    • Financial Press Releases
    • Chairman's letter to Shareowners
    • Details of Unclaimed Dividend
    • Filings with Stock Exchange
    • Shareholding Pattern
    • Stock Quotes
    • Statutory Communication
    • Policies
    • Credit Rating
    • Investor Communication
    • Investor Meet
    • Investor Contact
    • Investor Call
    • Accounts of Subsidiaries
  • Media & Press
    • Media coverage
    • Press Release
    • Media Kit
    • Media Contact
  • CSR
    • CSR Policy
    • Report on CSR activities – Wockhardt Foundation
    • CSR Strategy
    • Quarterly Report
    • Stakeholders Engagement
  • Home
  • >
  • Investor Connect
  • >
  • Filings with Stock Exchange
Archives
123Prev
Board Meeting Intimation
21 January, 2021
RECONCILIATION OF SHARE CAPITAL AUDIT REPORT FOR QUARTER ENDED 31ST DECEMBER, 2020
20 January, 2021
Disclosure under Insider Trading Regulation
20 January, 2021
Disclosure under Takeover Code Regulation
20 January, 2021
Request for issuance of Duplicate Share Certificate
14 January, 2021
REPORT ON CORPORATE GOVERNANCE QUARTER FOR THE QUARTER ENDED 31ST DECEMBER, 2020
14 January, 2021
STATEMENT OF INVESTORS COMPLAINTS FOR THE QUARTER ENDED 31ST DECEMBER, 2020
12 January, 2021
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (D & P) REGULATIONS, 2018 FOR THE QUARTER ENDED 31ST DECEMBER, 2020
11 January, 2021
Disclosure under Insider Trading Regulation
04 January, 2021
Disclosure under Takeover Code Regulation
04 January, 2021
123Prev
Get in touch
  • Corporate Office
  • International Offices
  • Research Centres
  • Manufacturing Plants
  • Adverse Event Reporting
  • SITEMAP
  • TERMS & CONDITIONS
  • Privacy Policy
wock-stock
For Registered Office / CIN etc. details,
please click here.
© 2016 wockhardt. All Rights Reserved.